Docetaxel-Kabazitaxel-Enzalutamide Sequence vs Docetaxel-Enzalutamide Sequence in Patients with Metastatic Cancer Resistant Prostate Cancer

Simple item page
dc.contributor.authorRichter Igorcs
dc.contributor.authorDvořák Jiřícs
dc.contributor.authorBartoš Jiřícs
dc.date.accessioned2018-09-25T12:14:28Z
dc.date.available2018-09-25T12:14:28Z
dc.date.issued2017cs
dc.format.extent5cs
dc.identifier.issn0862-495Xcs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/31260
dc.language.isoczecs
dc.publisherAmbit Mediacs
dc.publisher.cityPrahacs
dc.relation.ispartofseries0cs
dc.subjectprostate cancercs
dc.subjectmetastasescs
dc.subjectchemotherapycs
dc.subjecttargeted hormonal therapycs
dc.titleDocetaxel-Kabazitaxel-Enzalutamide Sequence vs Docetaxel-Enzalutamide Sequence in Patients with Metastatic Cancer Resistant Prostate Canceren
dc.titleSekvence docetaxel-kabazitaxel-enzalutamid ve srovnání se sekvencí docetaxel-enzalutamid u pacientů s metastatickým kastračně rezistentním karcinomem prostatycs
local.citation.epage289-293cs
local.citation.spage289-293cs
local.identifier.publikace4721
local.relation.issue30cs
Files
Collections